ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2831

A Subset of Natural Killer Cells Are Expanded in Synovial Fluid of Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis

Abhra Chandra Chowdhury, Smriti Chaurasia, Amita Aggarwal and Ramnath Misra, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: natural killer (NK) cells, reactive arthritis and synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

We have previously shown that there is an increase in IL-17 in the synovial fluid of patients with Reactive arthritis(ReA) and undifferentiated spondyloarthropathy(uSpA). Besides Th17 cells, IL-17 is produced by several innate cells such as NK, NKT , γδT and double negative T cells(DNT) To account for increased IL-17 we have enumerated these innate cells in the peripheral blood and synovial fluid of patients with ReA/uSpA.  

Methods:

Patients were labelled as Reactive arthritis if they had a typical clinical history of acute or subacute onset of asymmetrical oligoarthritis with a preceding history of diarrhoeal illness within 4 weeks and as uSpA if patients fulfilled ESSG criteria but didnot fit into any defined spondyloarthropathy.  10 to 30 ml of Synovial fluid was aspirated from the inflammed knee joint prior to corticosteroid injection along with peripheral blood in EDTA for cell analysis.   Peripheral blood (PB) of  28 patients with ReA/uSpA and  paired synovial fluid (SF)in 20 patients were collected between September 2014 and  June 2015 for analysis.  The percentage of  NK cells(CD56+CD3-)/NK cells(CD56bright) / NK cells(CD56dim) / NKT cells(CD3+/CD56+) , DNT cells(CD4–/CD8– αβTCR+CD3+)and γδT cells(γδTCR+CD3+)  were determined by flow cytometry (Beckman Coulter, USA)  using a panel of monoclonal antibodies (BD biosciences, USA)   In paired samples the percentage of cells were compared between the synovial fluid and peripheral blood by non parametric tests(Wilcoxon signed ranks test)

Results:

28 patients(male-25 female–3) with a median age 24(IQR 20-31) years were recruited .Of these 12 were ReA and 16 were uSpA.4 patients had chronic symptoms whereas 24 had acute episode.Knee was the most common joint involved followed by ankle.11 patients had evidence of enthesitis (most common-achilles tendinitis)whereas 3 patients had extra-articular involvement. The median frequency and interquartile range  of various cell population in the peripheral blood and synovial fluid are presented in Table 1.

Table 1.  Percentage (median and interquartile range) of various innate cells in peripheral blood and synovial fluid

Innate cells

Peripheral blood % median(interquartile range)

Synovial Fluid % median(interquartile range)

NK cells(CD56+CD3-)

8 (6.3-10.5)

10.6(5.7-13)

CD56 brightNK cells

0.5 (0-0.9)

4.4(0.35-8.45)**

CD56 dim NK cells

6.8 (0-10.3)

1.35(0.15-2.80)**

NKT cells

3.3(1.2-5.6)

2.2(1.40-3.75)

DNT cells

1.7(0.9-2.0)

1.8(1.2-2.2)

γδT cells

3.3(1.4-5.4)

1.5(0.85-3.15)*

** p < 0.005  * p <0.05

CD56 bright NK cells was significantly increased in synovial fluid(p=.000) and CD56 dimNK cells was significantly decreased in synovial fluid(p=0.001) in comparison to peripheral blood. As it is known that CD56 bright NK cells can produce IL17 , these cells can be a innate source of IL17 in the inflamed joints.Also γδT cells was significantly increased in peripheral blood (P=.022).

Conclusion:

CD56 bright NK cells which are cytokine producers are expanded in the synovial compartment as compared to peripheral blood and may be contributing to the production of IL-17 in ReA and uSpA. The increase of peripheral blood γδT cells is most likely related to its origin from the gut.


Disclosure: A. Chandra Chowdhury, None; S. Chaurasia, None; A. Aggarwal, None; R. Misra, None.

To cite this abstract in AMA style:

Chandra Chowdhury A, Chaurasia S, Aggarwal A, Misra R. A Subset of Natural Killer Cells Are Expanded in Synovial Fluid of Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-subset-of-natural-killer-cells-are-expanded-in-synovial-fluid-of-patients-with-reactive-arthritis-and-undifferentiated-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-subset-of-natural-killer-cells-are-expanded-in-synovial-fluid-of-patients-with-reactive-arthritis-and-undifferentiated-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology